A Phase 2 in Adult Subjects With Hereditary Angioedema

Clinical trial NCT06846398 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06846398
Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)

Start date: 2025-02-28
Primary completion: 2026-06-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.